BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...

BioNTech (NASDAQ:BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for their drug ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...

While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a ...

Atomi Financial Group Inc. bought a new position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) during the 3rd quarter, ...

Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...

Truist Financial Corp lowered its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 4.1% in the second quarter ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...